Skip to main content

Table 2 SUVmax, SUV41%/SUVaverage, and SUVpeak (mean ± SD of all datasets) of tumors and livers for each replay

From: For avid glucose tumors, the SUV peak is the most reliable parameter for [18F]FDG-PET/CT quantification, regardless of acquisition time

 

SUV R1.5 (mean ± DS)

SUV R2 (mean ± DS)

SUV R2.5 (mean ± DS)

SUV R3 (mean ± DS)

SUV R5 (mean ± DS)

SUV R10 (mean ± DS)

p ANOVA

Tumor

 SUVmax

17.4 ± 9.5 (R5, R10)

17.3 ± 9.6

17.2 ± 9.7

17.1 ± 9.6

16.9 ± 9.5

16.9 ± 9.7

0.0005

 SUV41%

10.4 ± 5.6 (R5, R10)

10.3 ± 5.5 (R5, R10)

10.2 ± 5.6 (R10)

10.2 ± 5.6

10.1 ± 5.5

10.1 ± 5.6

<0.0001

 SUVpeak

13.6 ± 8.3

13.6 ± 8

13.6 ± 8.1

13.5 ± 8

13.6 ± 8.1

13.5 ± 8.2

NS

Liver

 SUVmax

2.9 ± 0.5 (R2.5 → R10)

2.8 ± 0.5 (R3 → R10)

2.8 ± 0.5 (R5, R10)

2.7 ± 0.5 (R5, R10)

2.6 ± 0.5 (R10)

2.5 ± 0.5

<0.0001

 SUVaverage

2.2 ± 0.4

2.2 ± 0.4

2.2 ± 0.4

2.2 ± 0.4

2.2 ± 0.4

2.2 ± 0.4

NS

 SUVpeak

2.5 ± 0.4 (R2 → R10)

2.5 ± 0.4 (R5, R10)

2.4 ± 0.4 (R5, R10)

2.4 ± 0.4 (R5, R10)

2.4 ± 0.4

2.4 ± 0.4

<0.0001

  1. (R2) means a significant difference with the replay R2, (R2.5) with R2.5, (R3) with R3, (R5) with R5, and (R10) with R10